ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS


Year of Award:
2001
Status:
Complete
Award Type:
R43
Project Number:
HL069675
RFA Number:
PAR-99-101
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
WILLETT, CATHERINE E
Other PI or Project Leader:
N/A
Institution:
PHYLONIX PHARMACEUTICALS, INC.
Our overall aim is to use a molecular approach to isolate new genes involved in angiogenesis. We will treat zebrafish embryos with drugs and identify genes using subtractive library technology. Angiogenesis has been shown to be necessary for tumor growth